• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOXO IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOXO IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII Back to Search Results
Catalog Number 07028008190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/19/2022
Event Type  malfunction  
Manufacturer Narrative
Sample material was requested for investigation.The investigation is ongoing.
 
Event Description
The initial reporter questioned positive results for 1 patient tested for elecsys toxo igg (toxo igg) on a cobas e 801 analytical unit.On (b)(6) 2022 the patient had a toxo igg result from a non-roche method of 2.1 ui/ml (negative).The result from the e801 module was approximately 40 iu/ml (positive).On (b)(6) 2022 the patient had a toxo igg result from a non-roche method of 2.3 iu/ml (negative).The result from the e801 module was 42 iu/ml (positive).Western blot testing was performed on this sample and the presence of igg was not confirmed.On (b)(6) 2022 the result from the e801 module was 39.6 iu/ml (positive).No questionable results were reported outside of the laboratory.The e801 analyzer serial number was (b)(4).
 
Manufacturer Narrative
Calibration and qc were acceptable.The sample from 19-aug-2022 was received for investigation.The following results were obtained during the investigation: elecsys toxo igg: 47.0 iu/ml (positive).The sample was neutralizable: 8.6% of remaining titer.Recomline blot toxo igg: borderline with a weak gra7-band.Elecsys toxo igg avidity: 86% (high avidity).Elecsys toxo igm: 0.275 coi (negative).Based on these results, the investigation determined the sample was correctly positive.Based on the toxo igm and toxo igg avidity results an acute infection of the patient is not likely and a remote state of infection is suspected.The reagent performed within specification.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOXO IGG
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16185801
MDR Text Key308923044
Report Number1823260-2023-00141
Device Sequence Number1
Product Code LGD
UDI-Device Identifier04015630940301
UDI-Public04015630940301
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K073501
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Catalogue Number07028008190
Device Lot Number59823401
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient SexFemale
-
-